Spyre Therapeutics (SYRE) Shares Issued (2015 - 2022)
Spyre Therapeutics' (SYRE) quarterly Shares Issued came in at $10.1 million in Q4 2022, up 53.26% YoY from $6.6 million in Q4 2021, and up 53.26% on a QoQ basis from $6.6 million in Q4 2021.
Spyre Therapeutics (SYRE) Shares Issued (2015 - 2022) Analysis & Trends
Spyre Therapeutics (SYRE) has 8 years of Shares Issued data on file, last reported at $10.1 million in Q4 2022.
- Quarterly Shares Issued rose 53.26% year-over-year to $10.1 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $10.1 million (up 53.26% YoY) and the FY2022 annual result came in at $10.1 million, up 53.26% from the prior year.
- Shares Issued rose to $10.1 million in Q4 2022, from $6.6 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $5.4 billion in Q4 2020 to a low of $3.1 million in Q4 2018.
- A 5-year average of $1.1 billion and a median of $6.6 million in 2021 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2020 — Shares Issued surged 137662.54% — and 2021, when it plunged 99.88%.
- Tracing SYRE's Shares Issued over 5 years: stood at $3.1 million in 2018, then grew by 23.75% to $3.9 million in 2019, then surged by 137662.54% to $5.4 billion in 2020, then sank by 99.88% to $6.6 million in 2021, then soared by 53.26% to $10.1 million in 2022.
- The last three Shares Issued figures came in at $10.1 million (Q4 2022), $6.6 million (Q4 2021), and $5.4 billion (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Spyre Therapeutics | 9.13 Bn | 9.13 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 10.13 Mn |
| Dec 31, 2022 | 10.13 Mn |
| Dec 31, 2021 | 6.61 Mn |
| Dec 31, 2021 | 6.61 Mn |
| Dec 31, 2020 | 5.36 Bn |
| Dec 31, 2020 | 5.36 Bn |
| Dec 31, 2019 | 3.89 Mn |
| Dec 31, 2019 | 3.89 Mn |
| Dec 31, 2018 | 3.14 Mn |
| Dec 31, 2018 | 3.14 Mn |
| Dec 31, 2017 | 2.36 Mn |
| Dec 31, 2017 | 2.36 Mn |
| Dec 31, 2016 | 1.15 Mn |
| Dec 31, 2016 | 1.15 Mn |
| Sep 30, 2016 | 145,939.00 |
| Sep 30, 2016 | 145,939.00 |
| Jun 30, 2016 | 165,000.00 |
| Jun 30, 2016 | 165,000.00 |
| Dec 31, 2015 | 629,848.00 |
| Dec 31, 2015 | 629,848.00 |